BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1481 related articles for article (PubMed ID: 18325444)

  • 1. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
    Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
    Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol.
    Ng CT; Chee TS; Ling LF; Lee YP; Ching CK; Chua TS; Cheok C; Ong HY
    Europace; 2011 Jun; 13(6):883-8. PubMed ID: 21486912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
    Maron BJ
    Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.
    Pelliccia A; Maron BJ; Spataro A; Proschan MA; Spirito P
    N Engl J Med; 1991 Jan; 324(5):295-301. PubMed ID: 1824720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hypertrophic cardiomyopathy in young athletes.
    Corrado D; Basso C; Schiavon M; Thiene G
    N Engl J Med; 1998 Aug; 339(6):364-9. PubMed ID: 9691102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and significance of an isolated long QT interval in elite athletes.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; Behr E; Sharma S
    Eur Heart J; 2007 Dec; 28(23):2944-9. PubMed ID: 17947213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden death in athletes.
    Futterman LG; Lemberg L
    Am J Crit Care; 1995 May; 4(3):239-43. PubMed ID: 7787919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic patterns and systolic and diastolic functions of the heart in the highly trained football players with increased left ventricular mass.
    Maskhulia L; Chabashvili N; Kakhabrishvili Z; Akhalkatsi V; Chutkerashvili T
    Georgian Med News; 2006 Mar; (132):76-80. PubMed ID: 16636387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Athlete's heart and hypertrophic cardiomyopathy: contribution on clinical and morphologic differentiation].
    Bahlmann E; Kuck KH; Nienaber CA
    Dtsch Med Wochenschr; 2015 Jul; 140(15):1158-64. PubMed ID: 26230069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy.
    Pelliccia A; Maron MS; Maron BJ
    Prog Cardiovasc Dis; 2012; 54(5):387-96. PubMed ID: 22386289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic electrocardiographic changes in a junior athlete with unpredictable hypertrophic cardiomyopathy.
    de Gregorio C; Magliarditi A; Magaudda L
    Int J Cardiol; 2009 Nov; 137(3):e51-3. PubMed ID: 19411118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy and athlete's heart: a tale of two entities.
    Martín M; Reguero JJ; Castro MG; Coto E; Hernández E; Carro A; Calvo D; de la Tassa CM
    Eur J Echocardiogr; 2009 Jan; 10(1):151-3. PubMed ID: 18713777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
    Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sudden cardiac death in athletes is usually caused by undiagnosed heart disease. Cardiac screening of young athletes under discussion].
    Börjesson M; Nylander E
    Lakartidningen; 2005 Feb 21-27; 102(8):560-3. PubMed ID: 15786908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.